Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02402218
What this trial is testing

CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
Johns Hopkins University 144
Early research (Phase 1)Ended earlyNCT01425190
What this trial is testing

Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 16
Large-scale testing (Phase 3)Study completedNCT00239252
What this trial is testing

Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C

Who this might be right for
Hepatitis C
Astellas Pharma Inc
Post-approval studies (Phase 4)UnknownNCT00526448
What this trial is testing

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

Who this might be right for
Chronic Hepatitis C
Hospital Carlos III, Madrid 384
Not applicableStudy completedNCT07236268
What this trial is testing

Prevalence of HIV and Sexually Transmitted Infections in Migrant Communities in Slovakia

Who this might be right for
STIsHIVRapid Detection
Comenius University 660
Early research (Phase 1)Study completedNCT02195440
What this trial is testing

An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis

Who this might be right for
Hepatitis C Virus-infected Cirrhosis
Komagome Hospital 14
Not applicableStudy completedNCT01681420
What this trial is testing

Improving Blood Safety and HIV Testing in Brazil

Who this might be right for
HIVHerpes Simplex 2Hepatitis C+2 more
Vitalant Research Institute 11,900
Post-approval studies (Phase 4)Study completedNCT01447420
What this trial is testing

Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 129
Post-approval studies (Phase 4)Ended earlyNCT03723824
What this trial is testing

Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation

Who this might be right for
Chronic Hepatitis cLiver Transplant InfectionKidney Transplant Infection
Taichung Veterans General Hospital 14
Testing effectiveness (Phase 2)Study completedNCT01200420
What this trial is testing

Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects

Who this might be right for
Hepatitis C
Santaris Pharma A/S 38
Not applicableStudy completedNCT00629603
What this trial is testing

Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease

Who this might be right for
FibrosisChronic Liver Disease
Kaohsiung Medical University Chung-Ho Memorial Hospital 600
Not applicableActive Not RecruitingNCT03993925
What this trial is testing

Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong

Who this might be right for
Chronic Hepatitis CIntravenous Drug Usage
The University of Hong Kong 800
Not applicableStudy completedNCT03513796
What this trial is testing

Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure in NHS Tayside

Who this might be right for
Hepatitis C, Chronic
NHS Tayside 1,949
Post-approval studies (Phase 4)Ended earlyNCT00260208
What this trial is testing

Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

Who this might be right for
Liver TransplantHepatitis C
Novartis Pharmaceuticals 361
Not applicableStudy completedNCT01579162
What this trial is testing

Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation

Who this might be right for
Hepatitis C, ChronicNon-Alcoholic Fatty Liver Disease
HepQuant, LLC 48
Testing effectiveness (Phase 2)Study completedNCT00166296
What this trial is testing

Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients

Who this might be right for
Major Depressive DisorderHepatitis C, Chronic
Germans Trias i Pujol Hospital 133
Testing effectiveness (Phase 2)Study completedNCT00475176
What this trial is testing

S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Testing effectiveness (Phase 2)Study completedNCT00495391
What this trial is testing

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C

Who this might be right for
Chronic Hepatitis C
Romark Laboratories L.C. 64
Not applicableStudy completedNCT01647191
What this trial is testing

Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

Who this might be right for
Hepatitis C
Shanghai Mental Health Center 240
Not applicableStudy completedNCT02508090
What this trial is testing

Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 10
Next Page